Clinical trial

Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma

NCT02704767

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-06-01

PhasePHASE2

Study timeline

Study start (unknown)2016-06-01Date precision: month

Registry last updated2016-03-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

ApatinibDRUG

TarcevaDRUG · verified · RxNorm: Tarceva

PlaceboDRUG

Sponsors & collaborators

First Affiliated Hospital of Kunming Medical Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02704767 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.